Comparative analysis of the effectiveness of lipid — lowering drugs in the treatment of ophthalmic diabetes on the basis of clinical and laboratory studies

Babadzhanova Sh.A.

dc.contributor.advisor	Hidoyatov K.U.
dc.contributor.advisor	Kurbonova Z.Ch.
dc.contributor.author	Babadzhanova Sh.A.
dc.date.accessioned	2021-12-30T04:43:56Z
dc.date.available	2021-12-30T04:43:56Z
dc.date.issued	2021-05
dc.identifier.issn	2072-0297
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1312
dc.description.abstract	This article presents experimental data on the study of the possibility of early diagnosis of type 2 diabetes mellitus through the use of lipid-lowering therapy; statins are the drugs of choice. For the treatment of atherogenic dyslipidemia with high triglyceride levels and low concentration of high-density cholesterol (HDL-C), fibrates are traditionally used, including in patients with type 2 diabetes	en_US
dc.language.iso	en	en_US
dc.publisher	Молодой учёный, Казань	en_US
dc.relation.ispartofseries	19
dc.subject	Lipid, drug, ophthalmic diabete, laboratory study, type 2 diabetes	en_US
dc.title	Comparative analysis of the effectiveness of lipid — lowering drugs in the treatment of ophthalmic diabetes on the basis of clinical and laboratory studies	en_US
dc.type	Article	en_US